Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-02

Clinical Trial Update: Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of galantamine for improving dysfunction in people with bipolar disorder. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-05-02